Beijing Beilu Pharmaceutical Co., Ltd. (300016.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 8.13

From 52W high−12.96%

Volume21.93M

Market capCNY 5.67B

P/E (TTM)61.1x

P/S (TTM)3.9x

Div yield—

Key dataSep 18, 2026

Open

CNY 8.13

From 52W high

−12.96%

Volume

21.93M

Market cap

CNY 5.67B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

24.1x

P/E (TTM)

61.1x

RSI (14)

47.6

MomentumView details →

1D Return

−6.70%

YTD Return

+4.53%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

61.1x

EV/EBITDA

24.1x

EV/Sales

4.1x

P/S (TTM)

3.9x

P/B (TTM)

2.3x

ProfitabilityView details →

Gross Margin

46.07%

Net Margin

9.91%

EBITDA Margin

17.04%

ROE (TTM)

5.35%

ROA (TTM)

3.58%

Asset Turnover

0.37x

GrowthView details →

Revenue YoY

+17.40%

EPS YoY

+613.22%

FCF YoY

−93.28%

Revenue CAGR 3Y

+16.32%

EPS CAGR 3Y

+108.01%

EBITDA YoY

—

MomentumView details →

1D Return

−6.70%

YTD Return

+4.53%

1Y Return

−7.88%

RSI (14)

47.6

vs 50D SMA

−0.86%

vs 200D SMA

−6.70%

Capital & dividendView details →

Debt/Equity

0.24x

Current Ratio

2.39x

Quick Ratio

1.80x

Div Yield

—

Div Rate

—

Div Growth 1Y

−28.57%

EarningsView details →

EPS (Actual)

CNY 0.06

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.24B

Net Income (TTM)

123.17M

Op. CF (TTM)

232.85M

Latest newsMore news →

Beijing Beilu Pharmaceutical received a drug registration certificate from China's National Medical Products Administration for its 0.03% bimatoprost eye drops, approved as a Class 4 generic deemed to have passed consistency evaluation.19h ago

Beijing Beilu Pharmaceutical's deputy general manager Zong Li completed a share reduction plan, selling 30,600 shares via centralized bidding from July 14 to August 28, 2026, at an average price of 9.05 yuan per share.21d ago

Similar companies

常宝股份002478.SZ 精华制药002349.SZ 明月镜片301101.SZ 精锻科技300258.SZ 铭普光磁002902.SZ 广东鸿图002101.SZ Find similar companies →

Latest newsMore news →

Beijing Beilu Pharmaceutical received a drug registration certificate from China's National Medical Products Administration for its 0.03% bimatoprost eye drops, approved as a Class 4 generic deemed to have passed consistency evaluation.19h ago Beijing Beilu Pharmaceutical's deputy general manager Zong Li completed a share reduction plan, selling 30,600 shares via centralized bidding from July 14 to August 28, 2026, at an average price of 9.05 yuan per share.21d ago